Clearpoint Neuro Inc reports results for the quarter ended in March - Earnings Summary
08/05/2024 01:26
* Clearpoint Neuro Inc CLPT.OQ reported a quarterly
adjusted
loss of 16 cents per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -23 cents. The mean expectation of
three analysts for the quarter was for a loss of 19 cents per
share. Wall Street expected results to range from -20 cents
to -17 cents per share.
* Revenue rose 40.6% to $7.64 million from a year ago;
analysts
expected $6.99 million.
* Clearpoint Neuro Inc's reported EPS for the quarter was a
loss
of 16 cents.
* The company reported a quarterly loss of $4.15 million.
* Clearpoint Neuro Inc shares had fallen by 12.6% this
quarter and
lost 12.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 6.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Clearpoint Neuro
Inc is $10.00
This summary was machine generated from LSEG data May 8 at 12:26
a.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.19 -0.16 Beat
Dec. 31 2023 -0.20 -0.19 Beat
Sep. 30 2023 -0.25 -0.20 Beat
Jun. 30 2023 -0.19 -0.29 Missed